If you need more lookups,
subscriptions start at $34 USD/month.
Christopher McDaniel Location
United States
Christopher McDaniel Work
Senior Director, CMC @ (May 2024 - Present)
Sr. Director, Formulation Development @ (July 2022 - September 2023)
VP, Pharmaceutical Development @ Frequency Therapeutics (January 2019 - April 2022)
Prinicipal @ White Creek Pharma Advisors (January 2014 - January 2019)
Chief Scientific Officer @ (January 2008 - December 2013)
VP, Global Research and Development, Quality, and Project Management @ (January 2007 - January 2008)
Director, New Technology Assessment @ (January 2004 - January 2007)
Director, Pharmaceutical Development @ (January 2000 - January 2004)
Manager, Pharmaceutical Formulations @ (January 1997 - January 2000)
Research Scientist @ (January 1994 - January 1997)
R and D Chemist @ Penederm (January 1994 - January 1994)
Sr. Polymer Scientist @ Advanced Polymer Systems (January 1992 - January 1994)
Senior R and D Chemist @ (January 1989 - January 1992)
Christopher McDaniel Education
Brigham Young University
Ph.D. (Organic Chemistry)
University of Alabama, Birmingham
MBA
Brigham Young University
BA (Chemistry)
Christopher McDaniel Skills
Analytical Chemistry
Chemistry
Chromatography
Client Relations
Clinical Development
Contract Negotiation
Contractors
Cross-functional Team Leadership
Drug Development
Emulsions
FDA
Formulation
GLP
GMP
Global R&D
HPLC
Life Sciences
Lifesciences
Lyophilization
Manufacturing
Medical Affairs
New Business Development
Organic Chemistry
Personal Care
Pharmaceutical Industry
Polymer Science
Presentation Skills
Product Development
Proposal Writing
Public Speaking
Quality Auditing
Quality Inspection
R&D
Regulatory Affairs
Regulatory Submissions
Research and Development (R&D)
SOP
Sterile Processing
Strategic Planning
Team Building
Technology Transfer
Third-Party Vendor Management
Transdermal
U.S. Food and Drug Administration (FDA)
Validation
implants
microenapsulation
preformulation
Supplies
Development Projects
Planning
Consulting
Master Plan
Booths
Sales
Change Control
Cost Effective
Excess
Cancer
CMC
Science
Toxicology
Integration
Optics
Compliance Training
Sales Growth
Profit
Process Validation
Data Validation
Cogs
Continuous Process
Virology
Drug Delivery
Gene Delivery
Redwood
Supplements
Biodegradable Polymers
Project Management
Advanced Materials
Laboratory
Rx
Portfolio Assessment
Renewals
International Clients
Technology Evaluation
Energy
Fleet
Licensing
Operations
Oral Care
Research and Development R&d
Yields
Risk Assessment
Marketing
Project Planning
House
Encapsulation
Presentations
Yield
Team Coordination
Acne
CRO
Analytical Methods Development
Reviews
Regulatory
Government
Materials
Performance Reviews
Development Strategy
Skin
Budgets
Scientists
Due Diligence
Program Assessment
Research and Development
Christopher McDaniel Summary
Christopher McDaniel, based in United States, is currently a Senior Director, CMC at MycoMedica Life Sciences, PBC. Christopher McDaniel brings experience from previous roles at Sage Therapeutics, Frequency Therapeutics, White Creek Pharma Advisors and Fleet Laboratories. Christopher McDaniel holds a Ph.D. in Organic Chemistry @ Brigham Young University. With a robust skill set that includes Analytical Chemistry, Chemistry, Chromatography, Client Relations, Clinical Development and more. Christopher McDaniel has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Christopher McDaniel?
Find contact details for 700 million professionals.